These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9090418)

  • 1. MR and proton MR spectroscopy of the brain in hyperhomocysteinemia caused by methylenetetrahydrofolate reductase deficiency.
    Engelbrecht V; Rassek M; Huismann J; Wendel U
    AJNR Am J Neuroradiol; 1997 Mar; 18(3):536-9. PubMed ID: 9090418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent encephalopathy, reversible nerve conduction slowing, and MRI evidence of cerebral white matter disease in methylenetetrahydrofolate reductase deficiency.
    Walk D; Kang SS; Horwitz A
    Neurology; 1994 Feb; 44(2):344-7. PubMed ID: 8309589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term treatment with betaine in methylenetetrahydrofolate reductase deficiency.
    Ronge E; Kjellman B
    Arch Dis Child; 1996 Mar; 74(3):239-41. PubMed ID: 8787431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase deficiency: importance of early diagnosis.
    Fattal-Valevski A; Bassan H; Korman SH; Lerman-Sagie T; Gutman A; Harel S
    J Child Neurol; 2000 Aug; 15(8):539-43. PubMed ID: 10961793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging and proton spectroscopy in 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency.
    van der Knaap MS; Bakker HD; Valk J
    AJNR Am J Neuroradiol; 1998 Feb; 19(2):378-82. PubMed ID: 9504498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations.
    Kang SS; Wong PW; Bock HG; Horwitz A; Grix A
    Am J Hum Genet; 1991 Mar; 48(3):546-51. PubMed ID: 1998340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An early onset form of methylenetetrahydrofolate reductase deficiency: a report of a family from Kuwait.
    Al Tawari AA; Ramadan DG; Neubauer D; Heberle LC; Al Awadi F
    Brain Dev; 2002 Aug; 24(5):304-9. PubMed ID: 12142069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).
    Rozen R
    Thromb Haemost; 1997 Jul; 78(1):523-6. PubMed ID: 9198208
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.
    Kang SS; Zhou J; Wong PW; Kowalisyn J; Strokosch G
    Am J Hum Genet; 1988 Oct; 43(4):414-21. PubMed ID: 3177384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis.
    Rees MM; Rodgers GM
    Thromb Res; 1993 Sep; 71(5):337-59. PubMed ID: 8236162
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased neurotoxicity of arsenic in methylenetetrahydrofolate reductase deficiency.
    Brouwer OF; Onkenhout W; Edelbroek PM; de Kom JF; de Wolff FA; Peters AC
    Clin Neurol Neurosurg; 1992; 94(4):307-10. PubMed ID: 1335858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotic symptoms in severe MTHFR deficiency and their successful treatment with betaine.
    Bönig H; Däublin G; Schwahn B; Wendel U
    Eur J Pediatr; 2003 Mar; 162(3):200-201. PubMed ID: 12655429
    [No Abstract]   [Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase (MR) deficiency: thermolability of residual MR activity, methionine synthase activity, and methylcobalamin levels in cultured fibroblasts.
    Rosenblatt DS; Lue-Shing H; Arzoumanian A; Low-Nang L; Matiaszuk N
    Biochem Med Metab Biol; 1992 Jun; 47(3):221-5. PubMed ID: 1627352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase deficiency in a patient with phenotypic findings of Angelman syndrome.
    Arn PH; Williams CA; Zori RT; Driscoll DJ; Rosenblatt DS
    Am J Med Genet; 1998 May; 77(3):198-200. PubMed ID: 9605586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titration of betaine therapy to optimize therapy in an infant with 5,10-methylenetetrahydrofolate reductase deficiency.
    Ucar SK; Koroğlu OA; Berk O; Yalaz M; Kültürsay N; Blom HJ; Coker M
    Eur J Pediatr; 2010 Feb; 169(2):241-3. PubMed ID: 19434424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.
    Kluijtmans LA; van den Heuvel LP; Boers GH; Frosst P; Stevens EM; van Oost BA; den Heijer M; Trijbels FJ; Rozen R; Blom HJ
    Am J Hum Genet; 1996 Jan; 58(1):35-41. PubMed ID: 8554066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress of glutaric aciduria type I].
    Gao JZ; Luo XP
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):912-4. PubMed ID: 23324148
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of betaine on S-adenosylmethionine levels in the cerebrospinal fluid in a patient with methylenetetrahydrofolate reductase deficiency and peripheral neuropathy.
    Kishi T; Kawamura I; Harada Y; Eguchi T; Sakura N; Ueda K; Narisawa K; Rosenblatt DS
    J Inherit Metab Dis; 1994; 17(5):560-5. PubMed ID: 7837762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
    Kang SS; Wong PW
    Atherosclerosis; 1996 Jan; 119(2):135-8. PubMed ID: 8808490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT and MR appearance of the brain in two children with molybdenum cofactor deficiency.
    Appignani BA; Kaye EM; Wolpert SM
    AJNR Am J Neuroradiol; 1996 Feb; 17(2):317-20. PubMed ID: 8938304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.